Bioport Korea 2026 Q1: Sales +26.8% YoY, Net Profit Turns Positive, Net Cash Position

Consolidated Q1 2026 revenue: 21.4 billion won (+26.8% YoY from 16.9 billion)
Operating profit: 0.77 billion won; net profit: 0.71 billion won (vs full-year 2025 net loss of 14.0 billion)
Net cash: 3.3 billion won (net debt ratio -5.42%), debt ratio 46.7%
High customer concentration: 77.4% of sales from Costco
No shareholder returns: no dividends or buyback plans (no historical dividends)
R&D expense: 0.18 billion won (0.8% of revenue); new frying line completed
Credit rating: BBB+ (Korea Data)